AstraZeneca

AstraZeneca

Posted via Workday

Clinical Pharmacometrician

Apply by Nov 13, 2026

Posted Oct 19, 2026

Role at a glance

Salary
Not yet verified Check the description for pay details; an amount or pay period has not been verified.
Location
South San Francisco, California, United States
Employment
Full-time

Spotted an issue?

We’ll check it against the original posting.

Log in to report

Role Summary

AI-generated

The Clinical Pharmacometrician develops and implements quantitative strategies for a portfolio of cell therapy products. The role uses clinical and biomarker data to inform dose optimization, patient selection, clinical study decisions, and regulatory submissions.

What You'll Do

  • Build model-informed drug development approaches across the cell therapy portfolio.
  • Develop population PK, PKPD, exposure–response, mechanistic, and empirical models with cross-functional project teams.
  • Support the design and interpretation of clinical studies and inform dose selection and development decisions.
  • Align modeling strategies with regulatory expectations and support submissions, dose justifications, and scientific advice.
  • Monitor emerging methods, including QSP for cell therapies and AI/ML for biomarker integration.
  • Contribute to cell therapy modeling through speaking, publications, and consortium participation.

Generated from the employer's posting. Verify important details before applying.

View full posting

Qualifications

Minimum of a PhD in pharmacometrics, pharmacokinetics, biostatistics, or a related field, and 0–3 years of industry drug development experience in pharmacometrics. Requires proficiency with pharmacometrics software such as NONMEM, Phoenix/NLME, R, SAS, Python, or MATLAB; ability to work in a matrix team and influence decisions with a data-driven approach; knowledge of global pharmacometrics regulatory requirements; and ability to plan PopPK, PKPD, exposure–response, QSP, and Bayesian/adaptive approaches, integrating quantitative pharmacology with biomarkers, AI-enabled analyses, novel endpoints, and adaptive trial design.

Required

  • Minimum of a PhD in pharmacometrics, pharmacokinetics, biostatistics, or related field.
  • Minimum of 0 – 3 Years of industry drug development experience in pharmacometrics supporting decision-making, dose selection, study...
  • Hands-on experience and advanced proficiency with pharmacometrics software including NONMEM, Phoenix/NLME, R, SAS, Python, MATLAB, etc.
  • Ability to work in a matrix team environment and influence the team with a data-driven approach.
  • Knowledge of global regulatory, compliance, processes, standards and issues specific to pharmacometrics.
  • Ability to plan and implement pharmacometrics approaches (PopPK, PKPD, exposure–response, QSP, Bayesian/adaptive methods) that drive...
  • Integration of quantitative pharmacology with innovative biomarkers, AI-enabled analyses, novel endpoints, and adaptive trial design.

Preferred

  • Experience in application of AI and ML in pharmacometrics highly desirable.
  • Pharmacometrics experience across cell therapy platforms (CAR T, TCR, autologous, allogeneic, in vivo, etc.) and disease areas...

Original job description

Content provided by the employer


Job Description

Title: Clinical Pharmacometrician 

Location: South San Francisco

 

Position Summary:  

The Clinical Pharmacometrician will set and implement the quantitative strategy across a diverse portfolio of cell therapy products, translating advanced cellular kinetics and exposure–response modeling into dose optimization, patient selection, program decision and strategy. 


You will ensure innovative model-informed drug development (MIDD) is implemented to support AstraZeneca's cell therapy pipeline, integrating innovative modeling with novel cell therapy biomarkers, translational endpoints, and clinical data. Working cross functionally and with external partners, you will build mechanistic and empirical models, advise trial design and dose selection. 

 

Responsibilities: 

  • Build MIDD across cell therapy portfolio. 
  • Partner with project teams (physicians, clinical pharmacology scientists and statisticians, etc.) to build population PK, PKPD, and exposure-response models to support design and interpretation of clinical studies, influence key decisions in research and development, and support regulatory submissions of cell therapy products. 
  • Develop mechanistic and empirical models, enabling clear decision making, optimized dosing regimen, and streamlined development paths.  
  • Ensure modeling strategies align with regulatory expectations (e.g., FDA MIDD), supporting submissions, dose justifications, and scientific advice. 
  • Monitor and adopt emerging methodologies (QSP for cell therapies, AI/ML for biomarker integration, MIDD regulatory pilots, etc.). 
  • Advance AstraZeneca’s leadership through speaking, publications, and consortium participation in cell therapy modeling. 

 

Education and Experience: 

  • Minimum of a PhD in pharmacometrics, pharmacokinetics, biostatistics, or related field. 
  • Minimum of 0 – 3 Years of industry drug development experience in pharmacometrics supporting decision-making, dose selection, study design and regulatory interactions. 
  • Hands on experience and advanced proficiency in using pharmacometrics software including NONMEM, Phoenix/NLME, R, SAS, Python, MATLAB, etc. 
  • Be able to work in a matrix team environment and influence the team with a data-driven approach. 
  • Knowledge of global regulatory, compliance, processes, standards and issues specific to pharmacometrics. 
  • Ability to plan and implement pharmacometrics approaches (PopPK, PKPD, exposure–response, QSP, Bayesian/adaptive methods) that drive dose selection and enable go/no‑go decisions. 
  • Integration of quantitative pharmacology with innovative biomarkers, AI‑enabled analyses, novel endpoints, and adaptive trial design. 

 

Preferred Experience:  

  • Experience in application of AI and ML in pharmacometrics highly desirable. 
  • Pharmacometrics experience across cell therapy platforms (CAR T, TCR, autologous, allogeneic, in vivo, etc.) and disease areas (hematology, oncology, immunology, etc.) highly desirable. 

The annual base pay (or hourly rate of compensation) for this position ranges from $124,713.60 - $187,070.40.USD. Our positions offer eligibility for various incentives—an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles. Benefits offered include qualified retirement programs, paid time off (i.e., vacation, holiday, and leaves), as well as health, dental, and vision coverage in accordance with the terms of the applicable plans. 

 

Date Posted

18-Oct-2026

Closing Date

12-Nov-2026

Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.

AstraZeneca

About the company

AstraZeneca

Large Enterprise

AstraZeneca is a global biopharmaceutical company dedicated to the research, development, and commercialization of innovative medicines. Headquartered in Cambridge, UK, the company focuses on areas such as oncology, cardiovascular, renal, metabolism, and respiratory diseases, striving to deliver life-changing treatments to patients. With a strong commitment to scientific excellence and collaboration, AstraZeneca invests in cutting-edge technologies and partnerships to drive advancements in healthcare. The company is also committed to sustainability and corporate responsibility, aiming to make a positive impact on communities worldwide.